JF
NDRA icon

Jump Financial’s ENDRA Life Sciences NDRA Stock Holding History

Jump Financial’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-291
Closed -$2.05K – 1877
2024
Q3 		$2.05K Buy
+291
New +$22.5K ﹤0.01% 1577

Other funds holding NDRA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Jump Financial's NDRA Position: Q4 2024 in Review

Jump Financial sold out of ENDRA Life Sciences (NDRA) in Q4 2024, closing a stake of 291 shares — an estimated $2.05K sold.

Jump Financial first reported a position in NDRA in Q3 2024 and held it in 1 quarter. The position peaked at $2.05K in Q3 2024. 4 funds tracked by Wall St. Rank hold NDRA as of Q4 2024.

  • Jump Financial reported no remaining ENDRA Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Jump Financial sold 291 ENDRA Life Sciences shares in Q4 2024, an estimated $2.05K.
  • Jump Financial first reported a position in ENDRA Life Sciences in Q3 2024 and held it in 1 quarter.
  • Jump Financial's ENDRA Life Sciences position peaked at $2.05K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.